Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy

Climacteric

Volumn 12, Issue 5, 2009, Pages 404-409

  Benshushan, A ^a   Rojansky, N ^a   Chaviv, M ^a   Arbel Alon, S ^a   Benmeir, A ^a   Imbar, T ^a   Brzezinski, A ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

Climacteric symptoms; Menopause; Risk reducing bilateral salpingo oophorectomy

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; MENOPAUSAL SYNDROME; MENOPAUSE; MORBIDITY; OVARY CANCER; PATIENT SATISFACTION; POSTMENOPAUSE; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY;

ATROPHY; BEHAVIORAL SYMPTOMS; BREAST NEOPLASMS; EMOTIONS; FALLOPIAN TUBES; FEMALE; HOT FLASHES; HUMANS; MENOPAUSE; MENOPAUSE, PREMATURE; MIDDLE AGED; OVARIAN NEOPLASMS; OVARIECTOMY; QUALITY OF LIFE; RETROSPECTIVE STUDIES; RISK FACTORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SWEATING; TIME FACTORS; UROGENITAL SYSTEM;

EID: 70350686763     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130902780846     Document Type: Article

References (14)

1. McKinlay SM, Brambilla DJ, Posner J. The normal menopause transition. Maturitas 1992; 14:103-115
2. Bachmann GA. Vasomotor flushes in menopausal women. Am J Obstet Gynecol 1999;180: S312-16
3. Freeman EW, Sammel MD, Lin H, et al. Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstet Gynecol 2007;110:230-240
4. Woods NF. Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women's lives. Am J Med 2005; 118:S14-24
5. Kronenberg F. Hot flashes: epidemiology and physiology. Ann NY Acad Sci 1990;592:52-86
6. Greene JG. A factor analytic study of climacteric symptoms. J Psychosom Res 1976;20:425-430
7. Greene JG. Constructing a standard climacteric scale. Maturitas 1998;29:25-31
8. Madalinska JB, Hollenstein J, Bleiker E, et al. Quality-of-life effects of prophylactic salpingooophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer. J Clin Oncol 2005;23:6890-6898
9. Fry A, Busby-Earle C, Rush R, Cull A. Prophylactic oophorectomy versus screening: psychosocial outcomes in women at increased risk of ovarian cancer. Psycho-Oncology 2001;10:231-241 (Pubitemid 32466048)
10. Meiser B, Tiller K, Butow P, et al. Psychological impact of prophylactic oophorectomy in women at increased risk for ovarian cancer: a prospective study. Psycho-Oncology 2000;9: 496-503
11. Elit L, Epslen MJ, Butler K, Narod S. Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer. Familial Cancer 2001;1:149-156
12. Robson M, Hensley M, Barakat R, et al. Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy. Gynecol Oncol 2003;89:281-287
13. Madalinska JB, van Beurden M, Bleiker EM, et al. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingooophorectomy. J Clin Oncol 2006;24:3576-3582
14. Lord C, Duchesne A, Pruessner JC, Lupien SJ. Measuring indices of lifelong estrogen exposure: self-report reliability. Climacteric 2009;12:387-394